Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
The Era of Radical Healthcare Cost Containment Has Arrived!
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on intensified government efforts to contain drug ex... (4/23/2015)
   
The Era of Radical Healthcare Cost Containment Has Arrived! (4/23/2015)
Are These the Meaningful Changes at the CFDA We've Been Waiting For? (4/21/2015)
Ali Health Offers a Revolutionary Moment for China's Healthcare Industry (4/13/2015)
Birth of A New Novel Anticancer, Made in China (4/3/2015)
China's Leap Forward in Digital Medicine (3/30/2015)
China Launches New Drug Purchase Tender Policy as It Plans Drug Pricing Reform (3/25/2015)
IMS Reviews Chinese Hospital Market in the Third Quarter of 2014 (3/20/2015)
IMS: Overview of County Level Hospital Drug Market in China (3/20/2015)
A Decade Old Drug Launch in China with Important Insights Today (3/18/2015)
What Will China's New Normal Look Like? (3/17/2015)
China Telemedicine Tackles Long Term Care: Business Opportunities and Government Guidance (3/17/2015)
Review of Chinese Drug Evaluation and Registration in 2014 (3/17/2015)
Will Apple's Business Model Work In Pharmaceuticals? (3/12/2015)
China Announces Final Biosimilars Guideline (3/6/2015)
Overview of Chinese Legal/Regulatory Requirements for Pharmaceutical Trademarks and Naming (3/6/2015)
Upcoming Event: KAM in Pharma 3.0 Semina...  (4/24/2015) (free)
Chinese Polypeptide Drug Maker Emerges A...  (4/23/2015)
Sinovac Poised to Become A Challenger of...  (4/23/2015)
Fujian Initiates Overall Reform of Urban...  (4/23/2015)
Upcoming Event: Pharma Business Developm...  (4/23/2015) (free)
Upcoming Event: Pharmacognosy-2015  (4/23/2015) (free)
Upcoming Event: 2nd Annual Asia Biopharm...  (4/22/2015) (free)
Alibaba Enters Partnership for China's F...  (4/22/2015)
Recent Executive Moves  (4/22/2015)
CRO JV to Provide Circulating Tumor Cell...  (4/22/2015)
Nicholas Hall Reports 8% Growth for Chin...  (4/22/2015)
CFDA Issues Guidelines for Stability Stu...  (4/22/2015)
BMS Face Numerous Labor Lawsuits for Dis...  (4/22/2015)
China Pharmaceutical Qualified Person As...  (4/22/2015) (free)
New Report: Big Pharma's Internationalis...  (4/21/2015)
Teva Offers to Buy Mylan for $40.1 Billion
Global Strategic Partners Merck and Pfizer Finalize Agre...
Sun Pharma-Ranbaxy Merger Completed Finally
Actavis Closes Allergan Acquisition
Pfizer to Buy Hospira for US$15 Billion
Nicholas Hall Reports 8% Growth for Chinese OTC VMS Market in 2...
Hospital Oncology Drug Consumption of Six Cities in Yangtze Riv...
Review of Drug Consumption in Chinese County Level Hospitals
New Report: Chinese Human Vaccine Output Down 2.4% in 2014
Nicholas Hall: Chinese OTC Drug Market Growth Rebounded Slightl...
Sinovac Poised to Become A Challenger of Pfizer's Prevnar 13...
Alibaba Enters Partnership for China's First Cloud Hospital
CRO JV to Provide Circulating Tumor Cell Processing Services...
BMS Face Numerous Labor Lawsuits for Dismissing 1,000 Chines...
China Pharmaceutical Qualified Person Association Establishe...
CFDA Issues Guidelines for Stability Studies of Biologic...
Review of CDE Accepted Drug Registration Applications in...
Review of Drug Registration Applications on Three Fast T...
CFDA and NHFPC Publish Their 2015 Annual Budgets
Industry and Commerce Agencies to Reopen Healthcare Corr...
VellPharm Wins Lawsuit Against CFDA over Registration Proced...
USTR Releases 2014 Report on China's WTO Compliance Highligh...
China Makes Pledges on Pharma Business, Enforcement and IP a...
Two Medical Reps Handed Jail Sentences with Probation in Sha...
Fujifim to Sue Sihuan Pharma over IP Infringements Related t...
Tonghua Dongbao Pharma to Build $60M API Plant
UniTao Pharma Suspends Plan for Virgina API Plant
EU Withdraws GMP Certification of NCPC Subsidiary
USFDA Issues Warning Letter to Chinese API Producer Nova...
Lonza to Manufacture Sunshine Biopharma's Novel Anticanc...
New Report: Big Pharma's Internationalisation of R&D...
D-Pharm Gets CFDA Approval for Clinical Studes of Novel ...
Uni-Bio Science's Osteoporos NDA Accepted by CFDA
Australian and Chinese Researchers Make Drug Research Br...
Resverlogix Receives Two Chinese Patents for Its BET Inh...
Fujian Initiates Overall Reform of Urban Hospitals
Minor Amendment to the Provisions for National Essential...
The Lancet Urges China to Prevent Plagiarism and Fraud i...
NHFPC Minister LI Bin: Drug Price Unreasonable, Negotiat...
NHFPC: Online Medical Diagnosis and Treatment Restricted...
Chinese Polypeptide Drug Maker Emerges As New Billionaire ...
Recent Executive Moves
Recent Executive Moves
Sichuan Provincial CDC Director Under Investigation
Recent Executive Movements
Upcoming Event: KAM in Pharma 3.0 Seminar by Hanno Wolfr...
Upcoming Event: Pharma Business Development Course
Upcoming Event: Pharmacognosy-2015
Upcoming Event: 2nd Annual Asia Biopharma Leaders Summit...
Upcoming Event: Pharma Business Development Course
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links